Drug Reposition Studies and apply known drugs and compounds to new indications with
benefits such as the reduction of
R&D timelines by up to 3-5 years and the reduction of development costs due
to sunk research costs, the availability of clinical safety, toleration and
efficacy data and with improved probability of success. The drug reposition studies are conducted with methodology and software developed by the Cambridge University Hospitals NHS Trust and the Medical School of the University of Athens
Adress: Konitsis 3-5 Marousi 151-25 Greece.
Tel: +30 213 0281515